School of Medicine

Photo by Beth MillerTheodore Armstrong, a pre-doctoral fellow, and Jourdan Stuart, a first-year medical student, discuss a patient they examined with Will R. Ross, M.D., faculty supervisor, assistant professor of medicine and associate dean for diversity, at the Saturday Neighborhood Health Clinic in the Forest Park Southeast neighborhood.School of Medicine students are learning about social medicine on Saturday mornings in Forest Park Southeast.

Daniel Kelly, M.D., has been named director of the Division of Cardiovascular Diseases in the Department of Medicine.

Dean Shapiro plans to give updates on the School of Medicine’s key initiatives, including the tobacco-free initiative, addressing pandemic flu, and the New Interstate 64 project.

Using radiofrequency devices, School of Medicine heart surgeons have shortened atrial fibrillation surgery and made it easier to perform.

At the School of Medicine “smokeout” Nov. 16, employees who smoke will receive a special gift in exchange for their cigarettes.

A new device used at Siteman Cancer Center will protect staff from the possibility of incidental exposure to trace amounts of chemotherapy drugs generated during administration.

A specialist with the Barnes Retina Institute, Van Gelder also directs the Uveitis Service for the Department of Ophthalmology and Visual Sciences.

Photo by Robert BostonThe staff at the Washington University Diabetes Center at Barnes-Jewish Hospital discuss nutrition and insulin pumps at the Open House Sept. 25.

ColditzGraham A. Colditz, M.D., Dr.P.H., has been named the Niess-Gain Professor and associate director of Prevention and Control at the Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital. He will have overall responsibility for overseeing research, education, and community outreach in cancer prevention sponsored by the Center.

Scientists have identified a naturally occurring enzyme that can break down a key component of the brain plaques characteristic of Alzheimer’s disease. The finding may provide researchers with new opportunities to understand what goes wrong in the brains of Alzheimer’s patients and could one day help them seek new therapies.